Latest stories on RACC
RACC’s Oak Hill Bio Merger Brings $175M in Funding to Advance Angelman Syndrome Therapy
July 27, 2026
MarketChameleon67 · bullishm&a
RACC and Oak Hill Bio Join Forces to Push Angelman Syndrome Therapy Toward Phase 3 Milestone
July 27, 2026
MarketChameleon67 · bullishm&a
Research Alliance Corp III (RACC) files 8-K
SEC 8-K50 · neutralgeneral